Nurotron Biotechnology
Hangzhou
About Nurotron Biotechnology
Hangzhou Nurotron Biotechnology Co., Ltd., (Φ»║σ░öσ║╖τÑ₧τ╗Åτö╡σ¡ÉτºæµèÇ) is a high-tech enterprise providing nerve electronic products. The company is mainly involved in the R&D of multipath manual electrical cochlea systems, nationalization and clinical application of auditory brainstem implant equipment, strategy and technology enhancement of home-grown manual cochlea, and more. The company’s headquarters and production base are located in Hangzhou, China, and its R&D center is located in California, USA.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $48.3M
- Funding stage: Late Stage Venture
- Last round: Series E (Oct 2020)
- Website: nurotron.com
- Phone: 1-718-817-9901
Industries & Categories
Biotechnology, Electronics, Enterprise, Health Care
Social Profiles
Canonical: https://fsome.com/organization/nurotron-biotechnology-45405 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.